Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Two mesalazine regimens in the prevention of the post-operative recurrence of Crohn's disease: a pragmatic, double-blind, randomized controlled trial.
Caprilli R, Cottone M, Tonelli F, Sturniolo G, Castiglione F, Annese V, Papi C, Viscido A, Cammà C, Corrao G, Latella G. Caprilli R, et al. Among authors: corrao g. Aliment Pharmacol Ther. 2003 Feb 15;17(4):517-23. doi: 10.1046/j.1365-2036.2003.01462.x. Aliment Pharmacol Ther. 2003. PMID: 12622760 Free article. Clinical Trial.
Hepatobiliary alterations in patients with inflammatory bowel disease: a multicenter study. Caprilli & Gruppo Italiano Studio Colon-Retto.
Riegler G, D'Incà R, Sturniolo GC, Corrao G, Del Vecchio Blanco C, Di Leo V, Carratù R, Ingrosso M, Pelli MA, Morini S, Valpiani D, Cantarini D, Usai P, Papi C, Caprilli R. Riegler G, et al. Among authors: corrao g. Scand J Gastroenterol. 1998 Jan;33(1):93-8. doi: 10.1080/00365529850166275. Scand J Gastroenterol. 1998. PMID: 9489915
Prevention of post-operative recurrence of Crohn's disease requires adequate mucosal concentration of mesalazine. Gruppo Italiano per lo Studio del Colon e del Retto.
Frieri G, Pimpo MT, Andreoli A, Annese V, Comberlato M, Corrao G, Palumbo G, Sturniolo GC, Tonelli F, Caprilli R. Frieri G, et al. Among authors: corrao g. Aliment Pharmacol Ther. 1999 May;13(5):577-82. doi: 10.1046/j.1365-2036.1999.00501.x. Aliment Pharmacol Ther. 1999. PMID: 10233180 Free article.
Anastomotic configuration and mucosal 5-aminosalicyclic acid (5-ASA) concentrations in patients with Crohn's disease: a GISC study. Gruppo Italiano per lo Studio del Colon e del Retto.
Frieri G, Pimpo MT, Palumbo G, Tonelli F, Annese V, Sturniolo GC, Andreoli A, Comberlato M, Corrao G, Caprilli R. Frieri G, et al. Among authors: corrao g. Am J Gastroenterol. 2000 Jun;95(6):1486-90. doi: 10.1111/j.1572-0241.2000.2083_1.x. Am J Gastroenterol. 2000. PMID: 10894584
Oral mesalazine (5-aminosalicylic acid; Asacol) for the prevention of post-operative recurrence of Crohn's disease. Gruppo Italiano per lo Studio del Colon e del Retto (GISC).
Caprilli R, Andreoli A, Capurso L, Corrao G, D'Albasio G, Gioieni A, Assuero Lanfranchi G, Paladini I, Pallone F, Ponti V, et al. Caprilli R, et al. Among authors: corrao g. Aliment Pharmacol Ther. 1994 Feb;8(1):35-43. doi: 10.1111/j.1365-2036.1994.tb00158.x. Aliment Pharmacol Ther. 1994. PMID: 8186345 Clinical Trial.
Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC).
Corrao G, Tragnone A, Caprilli R, Trallori G, Papi C, Andreoli A, Di Paolo M, Riegler G, Rigo GP, Ferraù O, Mansi C, Ingrosso M, Valpiani D. Corrao G, et al. Int J Epidemiol. 1998 Jun;27(3):397-404. doi: 10.1093/ije/27.3.397. Int J Epidemiol. 1998. PMID: 9698126
534 results